Merry Jane profiles FRB’s Clean Stock program

Merry Jane did a full profile of FRB, interviewing Dr. Jonathan Vaught. Journalist Madison Margolin asked some great questions that show more of the details behind FRB’s process and philosophy.

Share
FRB is hiring!

Front Range Biosciences is hiring! We’re looking for Lab Technicians, Operations Support Manager, and Assistant Controller. See details here: https://www.frontrangebio.com/careers/

Share
UC Davis coverage summary – Newsweek, VICE, and others

FRB’s announcement about the partnership with UC Davis for cannabis genetics has received terrific coverage in the media! Below is a list of some of the top coverage. Newsweek, Weed

Share
Dr. Vaught Speaks on Panel on Cultivation Trends as Part of Canopy Jump Start

Our CEO, Dr. Jon Vaught, spoke at the Panel on Cultivation Trends as part of the Canopy Jump Start Conference. The focus of the conference was to help new startups

Share
Front Range Biosciences Partners with University of California, Davis for Cannabis Genomics Research

We are very proud to announce a partnership with the University of California, Davis to conduct research on the cannabis genome! Specifically, we are working on a new reference genome

Share
FRB is finalist for BizWest IQ award

We’re excited to announce that Front Range Biosciences has been chosen as a finalist for the BizWest Innovation Quotient (IQ) Award! We’re in prestigious company, alongside the two other finalists

Share
Dr. Vaught speaks at Nutrition Capital Network

Our CEO, Dr. Jon Vaught, gave a speech at the September 2017 gathering of the Nutrition Capital Network (NCN) during the Supply Side West Conference. Front Range Biosciences was the

Share
Fundraising coverage recap Sep 2017

We’ve received terrific coverage from the media about our fundraising announcement. We’re very thankful to the support of our investors, team, N6A (PR firm), customers, and the media. Here’s a

Share
Benzinga: Front Range Biosciences CEO Explains How Tissue Culture Can Help Marijuana Cultivators Drive Efficiency And Scale

Javier Hasse of Benzinga wrote a feature piece on Front Range Biosciences and our CEO, Dr. Jonathan Vaught. “Of course, scaling up brings benefits and challenges. As the size of

Share
Cannabis Agricultural Biotech Company Front Range Biosciences Raises $3 Million in Bridge Round Funding

We are pleased to announce the completion of our next financing, a $3M bridge round. Investor participation in the round includes Phyto Partners, Salveo Capital, Sand Hill Angels, HBS Angels of

Share